Devices › Device types
FDA product code LPL · class 2 · Ophthalmic
Lenses, soft contact, daily wear: medical device reports filed with FDA
4,882 reports carry this product code, 1994–2026; 13 brands with a page.
- 4,882
- reports with this product code
- 0% of all MAUDE reports
- 220
- reports, 12 months to August 2026
- 262 in the 12 months before
- 4.9%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code LPL is FDA's classification for "Lenses, soft contact, daily wear" (ophthalmic panel), a class 2 device. 4,882 medical device reports carry this product code, 0% of the MAUDE database, from January 1994 to August 2026.
220 reports arrived in the 12 months to August 2026, down 16% from 262 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (90.9%), malfunction (4.9%) and other (2.8%). 13 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Acuvue Oasys | 180 | 27 | 0% | 0.6% |
| Dailies Total 1 | 168 | 12 | 0% | 0% |
| Avaira Sphere Enfilcon A | 150 | 0 | 0% | 0% |
| Air Optix Night & Day Aqua | 85 | 9 | 0% | 0.7% |
| Focus Night & Day | 54 | 0 | 0% | 0.5% |
| Acuvue 2 | 46 | 5 | 0% | 0% |
| ACUVUE OASYS for ASTIGMATISM | 29 | 18 | 0% | 0% |
| Complete Moisture Plus | 3 | 0 | 0% | 6.9% |
| AdvanCE | 2 | 8 | 2.7% | 72.7% |
| Biofinity Toric (comfilcon A) | 2 | 16 | 0% | 0% |
| Amo Complete Moisture Plus | 1 | 0 | 0% | 8.6% |
| Ciba Vision Memory Lens | 1 | 0 | 0% | 49.7% |
| Clear Care | 1 | 0 | 0% | 1.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Vistakon | 1,065 | 21.8% |
| Ciba Vision | 618 | 12.7% |
| Pt Ciba Vision Batam | 260 | 5.3% |
| Bausch & Lomb | 211 | 4.3% |
| Alcon Laboratories | 19 | 0.4% |
| Bausch + Lomb | 12 | 0.2% |
| Advanced Medical Optics | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 655 | 13.4% |
| Disposable | 636 | 13% |
| Patient-device incompatibilitythe device did not suit the patient | 166 | 3.4% |
| Device operates differently than expectedthe device behaved unexpectedly | 143 | 2.9% |
| Improper or incorrect procedure or method | 120 | 2.5% |
| Nonstandard device | 94 | 1.9% |
| Difficult to removethe device was hard to remove | 83 | 1.7% |
| Reactiona reaction, type not specified | 76 | 1.6% |
| Torn material | 60 | 1.2% |
| Material split, cut or torn | 56 | 1.1% |
| Breakthe device broke | 48 | 1% |
| Replace | 42 | 0.9% |
| Product quality problem | 33 | 0.7% |
| Other (for use when an appropriate device code cannot be identified) | 31 | 0.6% |
| Contamination | 28 | 0.6% |
| Defective devicethe device was defective | 28 | 0.6% |
| Tears, rips, holes in device, device material | 25 | 0.5% |
| Device, removal of (non-implant) | 23 | 0.5% |
| Microbial contamination of device | 22 | 0.5% |
| Sticking | 22 | 0.5% |
Questions about lenses, soft contact, daily wear reports
What is product code LPL?
FDA's classification code for "Lenses, soft contact, daily wear", class 2, reviewed by the ophthalmic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
4,882 reports through August 2026, 220 of them in the latest 12 months.
Which brands appear most often?
Acuvue Oasys (180), Dailies Total 1 (168), Avaira Sphere Enfilcon A (150), Air Optix Night & Day Aqua (85) and Focus Night & Day (54). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.